Regeneron Pharmaceuticals, Inc. (REGN)

755.51 +9.05 (+1.21%) USD  |  NASDAQ  |  Apr 14, 16:00
754.35 -1.16 (-0.15%) After-Hours: 20:00
More

Regeneron Pharmaceuticals Return on Net Operating Assets (Annual)

Return on Net Operating Assets (Annual) Chart

View Return on Net Operating Assets (Annual) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets (Annual) Range, Past 5 Years

View Return on Net Operating Assets (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets (Annual) Benchmarks

View Return on Net Operating Assets (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
AbbVie, Inc. Upgrade